VentureCrowd wanted to be strengthened as the top alternative investment platform in the region.


Kicker worked to elevate the conversations that VentureCrowd were having with media to encompass the importance of the startup ecosystem and breakthroughs in healthtech at the height of the pandemic.


Biotech firm, EnGeneIC, who were capital raising on VentureCrowd, was featured on the Sunrise morning show for their breakthrough COVID-19 vaccine that protected those with compromised immune systems.

This media coverage supported a successful capital raise that was oversubscribed 5 times over, surpassing its original target of $1 million and eventually closing at $5 million.